Terms: = Head and neck cancer AND FOXO3, FKHRL1, 2309, ENSG00000118689, MGC31925, MGC12739, FOXO2, FOXO3A, O43524, AF6q21, FKHRL1P2, DKFZp781A0677
77 results:
1. Racial Disparities in head and neck cancer: It's Not Just About Access.
Whitehead RA; Patel EA; Liu JC; Bhayani MK
Otolaryngol Head Neck Surg; 2024 Apr; 170(4):1032-1044. PubMed ID: 38258967
[TBL] [Abstract] [Full Text] [Related]
2. RASSF1A promotes radiosensitivity in nasopharyngeal carcinoma by promoting foxo3a and inhibiting the Nrf2/TXNRD1 signaling pathway.
Si Y; Meng L; Zhang B; Wu Y; Du Q; Xu J; Qi J
Neoplasma; 2023 Oct; 70(5):633-644. PubMed ID: 38053374
[TBL] [Abstract] [Full Text] [Related]
3. foxo3a-regulated arginine metabolic plasticity adaptively promotes esophageal cancer proliferation and metastasis.
Sun W; Kou H; Fang Y; Xu F; Xu Z; Wang X; Yin R; Zhang Q; Jiang Q; Xu Y
Oncogene; 2024 Jan; 43(3):216-223. PubMed ID: 38049565
[TBL] [Abstract] [Full Text] [Related]
4. Correlation of DNA methylation and lymph node metastasis in papillary thyroid carcinoma.
Zhao F; Zhu S; Fang J; Dong H; Zhu C
Head Neck; 2023 Jul; 45(7):1654-1662. PubMed ID: 37097909
[TBL] [Abstract] [Full Text] [Related]
5. Knockdown of LAMB3 suppressed radioresistance in nasopharyngeal carcinoma via deactivating NRF2 signaling pathway.
Zhuang Q; Liu G; Huang W; He Z
J Radiat Res; 2023 May; 64(3):509-519. PubMed ID: 36947579
[TBL] [Abstract] [Full Text] [Related]
6. Identification of potential LncRNAs as papillary thyroid carcinoma biomarkers based on integrated bioinformatics analysis using TCGA and RNA sequencing data.
Feng JL; Zheng WJ; Xu L; Zhou QY; Chen J
Sci Rep; 2023 Mar; 13(1):4350. PubMed ID: 36928327
[TBL] [Abstract] [Full Text] [Related]
7. HSF1 activates the foxo3a-ΔNp63α-CDK4 axis to promote head and neck squamous cell carcinoma cell proliferation and tumour growth.
Wang Y; Zhu Q; Guo S; Ao J; Zhang W; Fei J; Yu S; Niu M; Zhang Y; Sherman MY; Xiao ZJ; Yi Y
FEBS Lett; 2023 Apr; 597(8):1125-1137. PubMed ID: 36700826
[TBL] [Abstract] [Full Text] [Related]
8. Contribution of microRNA-30d to the prevention of the thyroid cancer occurrence and progression: mechanism and implications.
Li Y; He Y; Chen Y; He Z; Yang F; Xing C
Apoptosis; 2023 Apr; 28(3-4):576-593. PubMed ID: 36695983
[TBL] [Abstract] [Full Text] [Related]
9. SN-38, an active metabolite of irinotecan, enhances anti-PD-1 treatment efficacy in head and neck squamous cell carcinoma.
Lee YM; Chen YH; Ou DL; Hsu CL; Liu JH; Ko JY; Hu MC; Tan CT
J Pathol; 2023 Apr; 259(4):428-440. PubMed ID: 36641765
[TBL] [Abstract] [Full Text] [Related]
10. Irradiation-induced exosomal HMGB1 to confer radioresistance via the PI3K/AKT/foxo3A signaling pathway in ESCC.
Du X; Zhang X; Dong J; Zou N; Guo D; Yao W; Wang X; Li S; Song C; Yan K; Shen W; Zhu S
J Transl Med; 2022 Nov; 20(1):507. PubMed ID: 36335371
[TBL] [Abstract] [Full Text] [Related]
11. DPCPX induces Bim-dependent apoptosis in nasopharyngeal carcinoma cells.
Pan S; Zhang X; Guo Y; Li Y
Cell Biol Int; 2022 Dec; 46(12):2050-2059. PubMed ID: 35989488
[TBL] [Abstract] [Full Text] [Related]
12. RBM47/SNHG5/foxo3 axis activates autophagy and inhibits cell proliferation in papillary thyroid carcinoma.
Qin Y; Sun W; Wang Z; Dong W; He L; Zhang T; Lv C; Zhang H
Cell Death Dis; 2022 Mar; 13(3):270. PubMed ID: 35338124
[TBL] [Abstract] [Full Text] [Related]
13. Downregulation of TMEM220 promotes tumor progression in Hepatocellular Carcinoma.
Li T; Guan L; Tang G; He B; Huang L; Wang J; Li M; Bai Y; Li X; Zhang H
Cancer Gene Ther; 2022 Jun; 29(6):835-844. PubMed ID: 34321624
[TBL] [Abstract] [Full Text] [Related]
14. MiR-155 Inhibitor-Laden Exosomes Reverse Resistance to Cisplatin in a 3D Tumor Spheroid and Xenograft Model of Oral cancer.
Sayyed AA; Gondaliya P; Mali M; Pawar A; Bhat P; Khairnar A; Arya N; Kalia K
Mol Pharm; 2021 Aug; 18(8):3010-3025. PubMed ID: 34176265
[TBL] [Abstract] [Full Text] [Related]
15. Real-time artificial intelligence for endoscopic diagnosis of early esophageal squamous cell cancer (with video).
Yang XX; Li Z; Shao XJ; Ji R; Qu JY; Zheng MQ; Sun YN; Zhou RC; You H; Li LX; Feng J; Yang XY; Li YQ; Zuo XL
Dig Endosc; 2021 Nov; 33(7):1075-1084. PubMed ID: 33275789
[TBL] [Abstract] [Full Text] [Related]
16. RETRACTED: Significance of halofuginone in esophageal squamous carcinoma cell apoptosis through HIF-1α-foxo3a pathway.
Wang Y; Xie Z; Lu H
Life Sci; 2020 Sep; 257():118104. PubMed ID: 32679143
[TBL] [Abstract] [Full Text] [Related]
17. PRAS40 Phosphorylation Correlates with Insulin-Like Growth Factor-1 Receptor-Induced Resistance to Epidermal Growth Factor Receptor Inhibition in head and neck cancer Cells.
Dougherty MI; Lehman CE; Spencer A; Mendez RE; David AP; Taniguchi LE; Wulfkuhle J; Petricoin EF; Gioeli D; Jameson MJ
Mol Cancer Res; 2020 Sep; 18(9):1392-1401. PubMed ID: 32467173
[TBL] [Abstract] [Full Text] [Related]
18. Pitavastatin induces apoptosis in oral squamous cell carcinoma through activation of foxo3a.
Lee N; Tilija Pun N; Jang WJ; Bae JW; Jeong CH
J Cell Mol Med; 2020 Jun; 24(12):7055-7066. PubMed ID: 32406610
[TBL] [Abstract] [Full Text] [Related]
19. Inhibition of
Yao LZ; Zhu YL; Liu JJ
Technol Cancer Res Treat; 2020; 19():1533033820917959. PubMed ID: 32281513
[TBL] [Abstract] [Full Text] [Related]
20. Role of foxo3A in Trastuzumab Combination Chemotherapy in Esophageal Squamous Cell Carcinoma.
Takahashi M; Fukuda K; Saikawa Y; Nakamura R; Wada N; Kawakubo H; Takeuchi H; Kitagawa Y
Anticancer Res; 2020 Apr; 40(4):1921-1930. PubMed ID: 32234881
[TBL] [Abstract] [Full Text] [Related]
[Next]
